About Deep 6 AI
Deep 6 AI is a Healthcare company based in Pasadena (United States) founded in 2013, and was acquired by Tempus in March 2025. AI enabled solutions for clinical trials. Deep 6 AI has raised $54.79 million across 6 funding rounds from investors including Tempus, SXSW and Techstars. Its website deep6.ai draws about 11 thousand monthly visits. Deep 6 AI offers products and services including Precision Matching Software and Cohort Builder. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is DEEP 6 AI INC. Its competitors include Medidata, Verily and TriNetX; 3 of its 3 listed competitors have raised funding.
Company details
Deep 6 AI was founded in 2013 in Pasadena, United States, within the health technology sector. Artificial intelligence solutions are developed to address clinical trial challenges. Unstructured data from electronic medical records is processed to identify eligible patients efficiently. Trial onboarding times and record analysis costs are reduced, while patient recruitment and outcomes are supported for hospitals and pharmaceutical companies operating in the U.S.
Products & Services of Deep 6 AI
Deep 6 AI offers a comprehensive portfolio of products and services, including Precision Matching Software and Cohort Builder.
Software that matches patients to clinical trials using data analysis.
Tool for identifying eligible patients in clinical studies quickly.
Apps and channels of Deep 6 AI
its YouTube channel Deep 6 AI has 65 subscribers and 7 videos.
Videos from Deep 6 AI
The most watched videos on Deep 6 AI's YouTube channel, Deep 6 AI (65 subscribers). Click a video to play it here.
More on Deep 6 AI.
Funding Insights of Deep 6 AI
Deep 6 AI has successfully raised a total of $54.79M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $26.89 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $54.79M
- Total Rounds 6
- Last Round Series C — $26.89M
- First Round $120,000
(Apr 2016)
- Investors Count 5
All 6 funding rounds of Deep 6 AI with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2022 | $26.89M | Series C | – | – | |
| Sep 2019 | $17.3M | Series B | – | Point72 Ventures | |
| Nov 2017 | $5.92M | Series A | – | – | – |
| Mar 2017 | Seed | – | – | ||
| Jun 2016 | $4.57M | Seed | – | – | |
| Apr 2016 | $120,000 | Seed | – | – |
6 investors in total: 6 institutional.
Investors in Deep 6 AI
Deep 6 AI has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Tempus, SXSW and Techstars.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and venture capital fund focused on the healthcare sector | novoholdings.dk | Hellerup, Denmark | ||
Venture capital fund focused on seed to growth stage fintech, deep tech, and enterprise tech companies | p72.vc | New York, United States | ||
Early-stage tech startups are invested in by GSR Ventures. | gsrventuresglobal.com | Beijing, China | ||
Startups are accelerated globally without sector restrictions through structured programs. | 2006 | techstars.com | New York, United States | |
Conferences and festivals are organized annually by SXSW in Austin. | 1987 | sxsw.com | Austin, United States | |
AI-based precision medicine solutions for oncology are provided. | 2015 | tempus.com | Chicago, United States |
Investor details for Deep 6 AI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Deep 6 AI
6 people are tracked at Deep 6 AI (3 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Wout Brusselaers | CEO & Founder | Leadership |
Amit Masaun | VP, Engineering | Leadership |
Diane Jackson | Director Account Management - Life Sciences | Leadership |
Robert Holsinger | Senior Infrastructure Engineer | Team |
Gabriel Katz | Software Engineer | Team |
Les Horne | Sr Solutions Architect | Team |
Complete people profiles for Deep 6 AI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Deep 6 AI
4 dated milestones of Deep 6 AI across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Deep 6 AI is founded.
- Funding First funding round of $120K.
- Funding Latest funding round, Series C, of $26.9M.
- Exit Acquired by Tempus.
Competitors of Deep 6 AI
Deep 6 AI has 3 listed competitors in our database, 3 of them funded. They include Medidata, Verily and TriNetX.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medidata.com | 1999 | New York, United States | $41.5M | 1,677 | Medidata is recognized as a leading provider of SaaS solutions for clinical research. | |
| verily.com | 2015 | Dallas, United States | $2.5B | AI-based solutions for health management are provided. | ||
| trinetx.com | 2013 | Cambridge, United States | $53M | 95 | Clinical trial management software is provided for researchers and professionals. |
Detailed competitors of Deep 6 AI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Deep 6 AI
The website of Deep 6 AI (deep6.ai) receives about 11.1K visits a month.
- Monthly visits11.1K
▼ 8.4% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Deep 6 AI (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Deep 6 Ai
Complete news archive for Deep 6 AI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deep 6 AI
Deep 6 AI was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Deep 6 AI is headquartered in Pasadena, United States. It is registered at Pasadena, California, United States.
Deep 6 AI is a funded company, having raised a total of $54.79M across 6 funding rounds to date. The company's 1st funding round was a Seed of $120K, raised on Apr 2016.
Deep 6 AI was founded in 2013 in Pasadena, United States, within the health technology sector. Artificial intelligence solutions are developed to address clinical trial challenges. Unstructured data from electronic medical records is processed to identify eligible patients efficiently. Trial onboarding times and record analysis costs are reduced, while patient recruitment and outcomes are supported for hospitals and pharmaceutical companies operating in the U.S.
Deep 6 AI offers Precision Matching Software and Cohort Builder.
Deep 6 AI has 6 investors. Key investors include Tempus, SXSW, Techstars, Novo Holdings, and Point72 Ventures.
Deep 6 AI operates through Deep 6 Ai Inc.
Yes. Deep 6 AI was acquired by Tempus in March 2025.